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transcriptional analysis of cleft 
palate in tGfβ3 mutant mice
J. Liu1,4, S. K. Chanumolu2,4, K. M. White3, M. Albahrani2, H. H. Otu2 & A. Nawshad1*
Cleft palate (CP) is one of the most common craniofacial birth defects, impacting about 1 in 800 
births in the USA. Tgf-β3 plays a critical role in regulating murine palate development, and Tgf-β3 
null mutants develop cleft palate with 100% penetrance. In this study, we compared global palatal 
transcriptomes of wild type (WT) and Tgf-β3 −/− homozygous (HM) mouse embryos at the crucial 
palatogenesis stages of E14.5, and E16.5, using RNA-seq data. We found 1,809 and 2,127 differentially 
expressed genes at E16.5 vs. E14.5 in the WT and HM groups, respectively (adjusted p < 0.05; |fold 
change|> 2.0). We focused on the genes that were uniquely up/downregulated in WT or HM at E16.5 
vs. E14.5 to identify genes associated with CP. Systems biology analysis relating to cell behaviors 
and function of WT and HM specific genes identified functional non-Smad pathways and preference 
of apoptosis to epithelial-mesenchymal transition. We identified 24 HM specific and 11 WT specific 
genes that are CP-related and/or involved in Tgf-β3 signaling. We validated the expression of 29 of the 
35 genes using qRT-PCR and the trend of mRNA expression is similar to that of RNA-seq data . Our 
results enrich our understanding of genes associated with CP that are directly or indirectly regulated 
via TGF-β.
Orofacial clefting is the most common craniofacial anomaly treated in pediatric hospitals and is the second most 
common birth defect, with a prevalence ranging from 1/500 to 1/2,500 in  humans1,2. Formation of a confluent 
palate is a precise orchestration of many palatal cellular processes, including cellular movement, cell death, and 
cell cycle  progression3,4. Many genes have been implicated in the etiology of cleft palate (CP). Transforming 
growth factor-beta (Tgf-β) isoforms (1, 2, and 3) are essential for proper development, including palate  fusion5,6. 
The roles of TGF-β in palatogenesis, participating in different phases of palate development, such as elevation, 
contact, and fusion, have been detailed  previously3. A number of studies suggest that TGF-β3 is a candidate 
gene for causing cleft palate in  mice2,  chickens7, and  humans8. The Tgf-β3 homozygous knockout (stated as 
homozygous, HM in this study) mouse model presents the phenotype of CP but no other major  anomalies9.
The process of palatogenesis is remarkably similar among vertebrates. In mice, the palatal shelves grow out 
bilaterally from the internal surfaces of the maxillary processes (~ E11.5). The shelves first vertically elongate 
on either side of the tongue (~ E12.5) and then elevate, becoming horizontal above the tongue as the tongue 
descends (~ E13.5). When the opposing shelves approach each other, the cells of the outer layer (periderm) 
covering the medial edge epithelia (MEE) slough off (~ E14,0), exposing the lateral surfaces of the underlying 
basal MEE cells to close contact with each other (also known as “adherence” or “fusion”), promoting formation 
of the midline epithelial seam (MES) (~ E14.5; Fig. 1A–C). The palatal epithelial seam subsequently disintegrates 
and reaches complete palatal mesenchymal confluency (by ~ E16.5; Fig. 1G,H). This process is governed by 
epithelial mesenchymal transition (EMT) and/or  apoptosis4, resulting in the mesenchymal portion of the two 
palatal shelves becoming continuous.
While both the wild type (WT) and HM palates proceed through the exact same stages of palatogenesis 
until E14.0 (i.e., growth, elongation, and elevation), the persistence of periderm on the Tgf-β3 HM palates at the 
final “adherence/fusion” stage at E14.5 hinders palatal MEE contact between opposite palatal shelves (~ E14.5, 
Fig. 1D–F) resulting in palatal cleft (Fig. 1I, J). It is evident that the MEE contact is strictly regulated by Tgf-β3 in 
WT to ensure desquamation of the periderm for immaculate  fusion10,11. The absence of Tgf-β3 fails to facilitate 
desquamation of the periderm and hinders fusion resulting in subsequent palatal cleft in HM. Therefore, in this 
study, we aim to assess the difference in the temporal gene expression for the WT and Tgf-β3 HM samples from 
open
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E14.5 to E16.5 to provide further understanding of genes functionally regulated by TGF-β3 during murine palatal 
fusion and examine their contribution to the development of CP using our previously established RNA-seq  data12.
Several studies have explored CP-related genes using RNA-seq in murine and human CP  samples13–15, how-
ever, downstream molecular mechanisms directly and indirectly controlled by Tgf-β3 signaling remain largely 
Figure 1.  Histological illustration of murine palate formation in WT (A–C, G, H) and TGFβ3 −/− (HM) mice 
(D–F, I, J). At 14.5 dpc, in WT palates the mid-palate region shows a complete union of a two-cell thick, basal 
medial edge epithelium (MEE), consisting of two opposite palates forming a tight epithelial seam in low (A) and 
higher magnifications (B); (C, yellow arrow). At 14.5 dpc, the HM (TGFβ3 −/−; D–F) palates demonstrate a 
trapped additional layer of flattened epithelium between the MEE of opposite palatal shelves (D); (E); (F, green 
arrow) [Figs. A–F are from J. Cell. Physiol. 230: 1,212–1,225, 2015. Wiley Periodicals, Inc., copyright John Wiley 
& Sons, Inc.]. At 16.5 dpc, the WT palates show complete disintegration of the seam and palatal mesenchymal 
confluence (G), higher magnification (H, red arrow). At 16.5 dpc, TGFβ3 −/− (HM) palates fail to fuse (I), 
higher magnification (J), and drift apart as face continues to grow, resulting in cleft palate consequently. In the 
HM palates at 16.5 dpc, the palatal epithelia are stratified (J, blue arrow).
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unexplored. We previously used RNA-seq to obtain the transcriptome of WT and Tgf-β3 HM mice at crucial 
stages of palatogenesis (E14.5 and E16.5)12. However, our previous study was confined to only assessing the 
expression profile of the 322 known CP genes in our RNA-seq dataset and did not explore the genes differentially 
expressed between the WT and HM groups and/or between the E14.5 and E16.5 time points. In this study, using 
the same RNA-seq data established in our previous paper, we applied new and advanced data quality control, 
filtering, quantification, normalization, differential expression, and systems biology approaches that were not 
previously employed, and explored all of the differentially expressed genes across all of the genotypes and time 
points. This way, we could identify potential key molecular components and possible underlying mechanisms 
of palate formation during development, failure of which may result in CP.
In particular, we identified the differentially expressed genes between genotypes (at a given time point) as 
well as the differentially expressed genes that changed temporally from E14.5 to E16.5 (for a given genotype). 
We further applied a comparative temporal transcriptome analysis of Tgf-β3 WT and HM mice and identified 
genes that were uniquely regulated by each genotype, which may contribute to CP formation in HM mice. Our 
systems biology analysis based on the Gene Ontology (GO) and Ingenuity Pathway Analysis (IPA; QIAGEN Inc., 
https ://www.qiage nbioi nform atics .com/produ cts/ingen uity-pathw ay-analy sis) platforms identified the biologi-
cal functions, molecular networks, and regulatory pathways (especially in relation to TGF-β signaling) for the 
differentially expressed genes. Finally, we validated the RNA-seq analysis results with real-time quantitative 
polymerase chain reaction (qRT-PCR) for 29 genes that are either known CP-related genes and/or genes that 
are regulated by TGF-β and fall under its downstream signaling pathways. For all of the 29 genes, the degree and 
direction of differential expression based on RNA-seq analysis agreed with the qRT-PCR results. Collectively, this 
data will enrich our understanding of TGF-β signaling during palate development and provide insight into the 
temporal regulation of downstream TGF-β-regulated genetic modulators that control cell morphology, cellular 
differentiation, apoptosis, and morphogenesis of the embryo.
Results
Our previously acquired RNA-seq  data12 involving wild type and Tgf-β3 homozygous knockout mouse models 
on E14.5 and E16.5 represented four sample groups (denoted as “WT14.5,” “WT16.5,” “HM14.5,” and “HM16.5”), 
each represented by two biological replicates (denoted as “a,” or “b”) for a total of eight samples. The average 
read count for the raw RNA-seq data was ~ 65.5 M paired-end reads (i.e., ~ 130.1 M total reads) per sample pro-
viding a high coverage of the transcriptome. The re-analysis of this data involved data trimming and filtering, 
normalization, expression quantification, clustering, differential analysis, comparative analysis, systems biology 
analysis, and qRT-PCR validation.
RNA-seq data processing and clustering. After trimming and filtering, the number of average total 
reads per sample came down to ~ 128.1 M (Supplementary Fig. 1A). The average read length was 101 bp in the 
raw data, which decreased to 95.86 bp following trimming and filtering (Supplementary Fig. 1B). On the other 
hand, the average Phred read quality score increased to 36.79 from 35.84 (Supplementary Fig.  1C); and the 
percentage of high-quality bases (bases with a quality score > 20) per sample increased to 99.20% from 96.28% 
(Supplementary Fig. 1D) following trimming and filtering. Therefore, both the total number of reads and the 
average read length parameters showed small changes in quantity after trimming and filtering; but this resulted 
in significant data quality improvement.
RNA-seq analysis generated expression data for 103,215 transcripts. Transcripts that showed a TPM value of 
less than 1 in both samples in all of the four groups were eliminated from downstream analysis leaving 52,475 
transcripts. Biological replicates showed high degree of correlation (r > 0.98). In Supplementary Fig. 2, we show 
the hierarchical clustering of the samples using all 52,475 transcripts. This global unsupervised grouping reveals 
that the samples were separated clearly by time as there are two main clades where one clade only consists of 
E14.5 samples and the other clade only consists of E16.5 samples. The effect of genotype on the transcriptional 
profiling was subtle because in the clustering tree we do not see a grouping based on the genotype neither glob-
ally, nor within a time point. Hence, there is a need for supervised analysis methods to identify the differences 
in gene expression due to genotypic variance. Furthermore, the height of the branching points in Supplementary 
Fig. 2 both for the E14.5 and E16.5 sample groups implied that the similarity between the WT and HM groups 
was higher at E14.5 than it was at E16.5. This is because of the shorter branch lengths among samples in the E14.5 
clade compared to the branch lengths among samples in the E16.5 clade. Therefore, the samples at E16.5 showed 
a more divergent transcriptional profile and thus the effects of Tgf-β3 knockout were more pronounced at E16.5.
Differential expression analysis. Differential expression analysis also showed the stark temporal dif-
ference in gene expression between samples (Table 1). There were 4,115 and 5,304 significantly differentially 
expressed genes (SDEG) between the E16.5 and E14.5 time points for the WT and HM samples, respectively 
indicating that the temporal transcriptional change in HM samples was more widespread than in normal con-
trols. Furthermore, in both genotypes, the number of upregulated genes with time (2,421 for WT and 3,153 for 
HM) was more than the number of downregulated genes (1,694 for WT and 2,151 for HM) showing that tran-
scriptional induction overshadowed transcriptional silencing. This difference in up/downregulation was further 
emphasized when we applied a 2.0-fold change (FC) cutoff (on top of the adjusted p < 0.05 cutoff) to define 
SDEGs. Most of the upregulated genes survived this FC cutoff (1,675 out of 2,421 in WT and 1,936 out of 3,153 
in HM had an |FC|> 2.0); but the number of SDEG that were downregulated decreased dramatically (134 out 
of 1,694 in WT and 191 out of 2,151 in HM had an |FC|> 2.0). This further underlined the trend of significant 
transcriptional induction with time.
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We observed a very subtle difference between the two genotypes at a given time point. At days E14.5 and 
E16.5, there were only 13 and 38 SDEGs between the WT and HM samples, respectively. In concordance with 
the unsupervised hierarchical clustering results, we saw a greater difference between the genotypes at E16.5. This 
was further strengthened by observing 13 SDEGs between the two genotypes with an |FC|> 2.0 at E16.5, while 
there were no SDEGs between the WT and HM samples with an |FC|> 2.0 at E14.5.
WT specific and HM specific gene identification. Since a direct comparison between the HM and WT 
groups yielded a very subtle difference, we defined the effect due to Tgf-β3 knockout by comparing the temporal 
SDEGs in the two groups. Following our adjusted p < 0.05 and |FC|> 2.0 cutoffs, we compared the 1,675 and 
1,936 SDEGs that were upregulated in E16.5 vs. E14.5 in the WT and HM groups, respectively. We identified 
429 genes that were upregulated in the WT group, but not in the HM group; similarly, we identified 690 genes 
that were upregulated in the HM group, but not in the WT group. Conversely, we compared the 134 SDEGs 
downregulated in E16.5 vs. E14.5 in the WT group with the 191 SDEGs downregulated in E16.5 vs. E14.5 in 
the HM group. We identified 72 genes that were downregulated in the WT group, but not in the HM group and 
similarly we identified 129 genes that were downregulated in the HM group, but not in the WT group. These 
results are summarized in Fig. 2A. We called the 501 (429 + 72) SDEGs uniquely up/downregulated in the WT 
group “WT specific”; and similarly, we called the 819 (690 + 129) SDEGs uniquely up/downregulated in the HM 
group “HM specific.”
In Fig. 2B, we show the hierarchical clustering of the 1,320 (501 + 819) WT and HM specific SDEGs across 
the four sample groups. This visual representation of expression values (heatmap) clearly shows how WT specific 
genes are significantly up/downregulated between WT E14.5 and WT E16.5 samples, whereas the expression 
of these genes remains “not significantly altered” between the HM E14.5 and HM E16.5 samples. A similar (but 
complementary) observation holds for the HM-specific genes. Figure 2B also shows the sample similarity based 
on genes specific to the genotypes, which clustered the biological replicates together and grouped the samples 
in E14.5 under the same clade. This implies that the temporal difference in the dataset was more dominant than 
the genotypic difference as we do not see samples from the same genotype in the two different time points group 
together. The HM samples at E16.5 stood out as a distinct group, which is reasonable as the phenotypic difference 
between the genotypes was not visible at E14.5 but emerged clearly at E16.5, making the HM samples at E16.5 
a distinctly separate phenotypic group among the four.
Figure 2.  Hierarchical clustering of 501 (429 + 72) WT-specific and 819 (690 + 129) HM specific genes with 
the color bar showing the row z-score. (A) Comparison of significantly differentially expressed genes (SDEGs) 
between E16.5 and E14.5 in the WT and HM groups. WT-Specific Up  (WSU): genes uniquely upregulated in 
the WT group at E16.5; WT-Specific Down  (WSD): genes uniquely downregulated in the WT group at E16.5; 
HM-Specific Up  (HMU): genes uniquely upregulated in the HM group at E16.5; HM-Specific Down  (HMD): 
genes uniquely downregulated in the HM group at E16.5, (B) hierarchical clustering of all four groups (eight 
samples) using the 501 (429 + 72) WT-specific and 819 (690 + 129) HM-specific genes identified in (A), (C) 
Significantly enriched Gene Ontology (GO) categories in the WT-specific and HM-specific gene lists (sample 
genes in the groups are shown), fold change of relevant WT- and HM-specific genes.
5
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:14940  | https://doi.org/10.1038/s41598-020-71636-0
www.nature.com/scientificreports/
Functional analysis. In order to understand the genes and corresponding signaling network and func-
tional mechanisms that would explain the differences observed between HM and WT samples across E16.5 
and E14.5 time points, we highlighted the GO functional categories and KEGG pathways that were statistically 
significantly enriched in the WT and HM specific gene lists (Fig. 2C). A complete list of SDEGs, enriched GO 
categories and KEGG pathways can be found in the Supplementary Data. In Table 2, we list 24 HM-specific and 
11 WT-specific genes based on their functional relevance by any one or more of the following criteria: (1) falling 
under the TGF-β signaling pathway, (2) contributing to palatogenesis or cleft palate in mice, (3) being involved 
in palatal cellular processes, such as EMT, apoptosis, differentiation, proliferation that are functional in palatal 
and craniofacial morphogenesis, and (4) being directly or indirectly regulated by TGF-β signaling.
Systems biology analysis. Using IPA, we analyzed the signaling networks and crosstalks amongst the 
downstream molecules that could be uniquely functional in WT and HM palates. Our network analysis results 
suggest that the TGF-β, ERK/MAPK, p38MAPK and PI3K/AKT pathways directly regulate p38MAPK in WT 
(Fig. 3A and Supplementary Fig. 3), which is not the case in HM (Fig. 3B and Supplementary Fig. 7). The canoni-
cal pathway analysis using IPA further strengthened this observation when we specifically considered the TGF-β 
signaling pathway separately for WT specific genes (Fig. 3A) and for HM specific genes (Fig. 3B). Furthermore, 
we showed that Goosecoid (Gsc) is downregulated by TGF-β signaling in WT (Fig. 3A), whereas, in the HM, 
TGF-β signaling downregulates transcription factor Tlx2 (Fig. 3B). Finally, our results suggest that, in both in 
WT and HM, TGF-β signaling regulates expression of neither Smads nor of transcripts encoding proteins that 
act upstream or downstream of Smads (Fig. 3A,B; Supplementary Figs. 3 and 7).
We identified WT specific genes that are also TGF-β downstream target genes. When we overlaid the Epithe-
lial Mesenchymal Transition (EMT) functional category on these genes, we observed that only two genes were 
selected (Supplementary Fig. 4a). When we similarly overlaid the “cell death” functional category on the same 
gene list, we observed nine selected genes (Supplementary Fig. 5a). These results potentially demonstrate that 
in WT, TGF-β signals to regulate “cell morphology” and “differentiation” that facilitate apoptosis over EMT as 
the number of TGF-β downstream target genes are predominantly pro-apoptotic genes but not EMT. We further 
analyzed the mechanistic networks generated by IPA that involve TGF-β signaling. These networks show the 
interaction among upstream regulators that best explain the changes observed in the SDEG list. We performed 
this analysis for WT specific genes and found that these upstream regulators were predominantly pro apoptotic, 
(12 out of 14, Supplementary Fig. 5b) not EMT (none out of 14, Supplementary Fig. 4b) genes.
qRT-PCR validation. We further assessed the expression levels of the 29/35 differentially expressed genes 
listed in Table 2 using real-time qRT-PCR. Our qRT-PCR results were all in agreement with our RNA-seq results 
(Table 2), which demonstrated that in WT, Cdh1, Ocln, F2rl1, and Tnfrsf11b were uniquely upregulated (folds 
of increase: 4.19, 5.84, 4.97, and 3.39, respectively) while Fndc3c1, Dlx1, and Gas2 were uniquely downregulated 
(folds of increase: − 8.99, − 6.89, and − 7.18, respectively) at E16.5 when compared to E14.5 (Fig. 4A). Similarly, 
in HM palates, genes that uniquely showed upregulation at E16.5 in RNA-seq data (Table 2), including Chrng, 
Col2a1, Col11a1, Col11a2, L1cam, Adam12, Fas, Hspg2, Lox, Itgb4, Klf5, Cldn1, and Nrcam, exhibited signifi-
cantly increased mRNA expression in qRT-PCR (folds of increase > 4.02), when compared to E14.5 (Fig. 4B). 
Similarly, qRT-PCR results verified that Wnt9b, Alx4, Pax1, Kcp, Msx1, Ppp1r17, Twist1, and Wnt5a were also 
in concordance with RNA-seq data, presenting downregulated mRNA expression (folds of decrease <  − 4.99) 
uniquely in HM (Fig. 4B).
Discussion
All isoforms of TGF-β are involved in both palatal epithelial and mesenchymal cell proliferation, differentiation, 
transformation, and  apoptosis16. TGF-β3 plays a distinctive role in periderm removal, palatal fusion and seam 
disintegration chronologically that involves crosstalk and reciprocal signaling between the two cell populations 
by epithelial-mesenchymal interaction (EMI)17,18, which cannot be achieved by other  isoforms10,11. Therefore, in 
this study, we analyzed Tgf-β3 HM whole palates to accurately explain the global TGF-β3 signaling during palate 
development. Usage of both epithelial and mesenchymal cells is a standard practice as previously  done19,20. In 
one of the most elegant studies of the palatal transcriptome analysis by NIH Facebase consortium, the authors 
also used regions of palate with a combination of both palatal epithelia and  mesenchyme13.
Our differential expression analysis showed a very subtle difference between the WT and HM palates—there 
were only 13 and 38 SDEGs between the WT and HM samples, respectively, at days E14.5 and E16.5 (see Supple-
mentary Data). In agreement with the unsupervised hierarchical clustering data, we noticed a greater difference 
between the genotypes at E16.5. This difference was not only in numbers but also in the degree of differential 
expression. When the |FC|> 2.0 cutoff was employed, there were no SDEGs at E14.5 and only 13 SDEGs at E16.5 
between the HM and WT groups (Table 1). This observation may be attributable to the obvious phenotypical 
difference, a palatal cleft at E16.5 and no difference at E14.5. Interestingly, 9 out of the 13 SDEGs in HM vs. WT 
at E16.5 were epithelial-specific genes with a majority of them being involved in palate deformities and cleft 
palate (Table 3). Henceforth, the differences between these two genotypes mainly impacted palatal epithelial 
cell-specific function, which is in accordance with the expression of TGF-β3 in WT or lack of it in HM. 
The subtle difference in gene expression at a given time point is likely to trigger larger downstream changes 
through direct and/or indirect regulatory signaling that results in a phenotypic difference. Such a large effect 
would be observed through variations in the temporal gene expression patterns for the two genotypes, which 
also accounts for any subtle cell population differences as direct comparisons between the genotypes are not 
involved. Therefore, we focused on genes that show temporal changes in WT (from E14.5 to E16.5) due to the 
presence of Tgf-β3, which are not identified as changed in HM (from E14.5 to E16.5) due to the absence of Tgf-β3 
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and vice versa. In order to identify genes that show temporal difference uniquely in the WT or HM groups, we 
identified WT specific and HM specific gene lists (Fig. 2A). The functional analysis of these gene lists (Fig. 2C, 
Supplementary Data) render GO categories and KEGG pathways that are statistically significantly enriched in 
the WT or HM, such as the “apoptotic process,” “cell adhesion molecules (CAMs),” and “focal adhesion.” These 
lists show specific signaling pathways and TGF-β downstream molecules modulating both the epithelial and 
the mesenchymal cellular functions that are unique to WT and HM, resulting in immaculate palatogenesis in 
WT but cleft in HM.
In the Supplementary Data, we also list the 1,308 genes commonly up/down regulated between E16.5 and 
E14.5 both in WT and HM groups. The rationale behind the table is to describe the common genes that are 
responsible for phases that are common in both WT and HM, such as palatal cell proliferation, differentiation, 
transformation and apoptosis. These cellular changes are ongoing in both genotypes, hence, the genes listed in 
this Supplementary Data represent a common palatal cellular behavior and function that may not necessarily 
imply genes that can trigger cleft palate. Of note among commonly upregulated genes are Sntn, which participates 
in cell growth/maintenance and is involved in cell communication process in the  nasopharynx21, and Tmem212, 
which codes for a transmembrane protein known to interact with transcription factor Tcf12, an important par-
alog of Tcf422 and Forkhead box k2 (Frk2). Frk2 is an important regulator palatal cell proliferation via activation 
of the phosphoinositide 3-kinase/AKT  pathway23. Other genes to names are, Ppp1r32, which is a substrate for 
cGMP-dependent protein kinase and is involved in central nervous system development and intracellular signal 
 transduction24, is upregulated in both WT and HM palates. It implements protein serine/threonine phosphatase 
inhibitor activity and inhibits phosphatase activities of protein phosphatase 1 (Pp1) and protein phosphatase 2A 
(Pp2A) complexes. Pp1 and Pp2A were reported by Weston et al.25 to account for virtually all detectable serine/
threonine protein phosphatase activity during the development of embryonic palate. We also observed com-
mon upregulation of Tspan1 and 33 in both WT and HM going from E14.5 to E16.5. Tspan1have been shown 
to play crucial roles in biologic processes including cell adhesion, proliferation, differentiation, and  migration26. 
Our data suggest that the role of Tspans may be limited to cellular proliferation and differentiation via Smad 
pathways. Another commonly upregulated transcript is Tnfrsf11a (RANK), which is a key regulator of bone 
 homeostasis27. As early as E14.5, mesenchymal condensations undergo chondrogenesis initially and ultimately 
membranous ossification that give rise to the hard  palate28. We expect the palatal cells express RANK to regulate 
osteoclast function in palatal bone formation in both genotypes. In terms of epithelial markers, Krt13, which has 
been shown to be expressed in the suprabasal layer of stratified palatal keratinized  epithelia29, is also among the 
commonly upregulated transcripts. Krt4, a type II cytokeratin, is specifically expressed in differentiated layers 
of all of oral mucosal epithelia along with family member Krt1330. Similar to Krt13, Krt4 is also upregulated in 
both WT and HM. Showing a similar expression pattern to Krt13 among commonly upregulated transcripts is 
Sprr3 (aka Loricrin), a marker for terminally differentiated keratinized and non-keratinized oral  mucosa31. This 
is potentially due to the fact that palatal epithelia undergo significant stratification with terminally differentiated 
keratinized epithelia covering the oral side of the palatal lining in both WT and HM palates.
Using IPA, we identified several novel findings which may suggest, and potentially imply, new signaling net-
work molecules as well as cellular functions. Our data suggests that TGF-β signaling may induce palatogenesis 
through regulating p38MAPK in WT palates (Fig. 3A,B, Supplementary Figs.3 and 7). These findings are in 
agreement with previous  work32–34 showing p38MAPK activation by TGF-β signaling during palatogenesis. It 
has been previously demonstrated that in palatogenesis TGF-β3 signals through the SMAD  pathway35–38. Our 
results indicate no change in SMADs and its down- and up-stream genes at the mRNA levels both for WT and 
HM palates (Fig. 3A,B, Supplementary Figs. 3 and 7). This observation does not necessarily imply an inactivation 
of the SMAD pathway as transcriptional level activity does not always imply protein level functionality. On the 
other hand, these results may imply non-Smad pathways to be also at play both in the WT and HM while in HM, 
unlike WT, this signaling cascade does not include p38MAPK (Supplementary Figs. 3 and 7).
Uniquely in the WT palate, Goosecoid (Gsc), a homeobox-containing gene, is downregulated by TGF-β sign-
aling in palatogenesis (Fig. 3A). Gsc mutant mice display defects in the pharyngeal muscles and the pharyngeal 
 mucosa39. TGF-β signaling is known to promote EMT by regulating the Gsc gene during embryonic Spemann’s 
organizer  formation40 as well as breast cancer  metastasis41. Since GSC is known to be a homeobox transcription 
factor that promotes EMT, it is likely that apoptosis is favored for seam disintegration since an EMT gene, such 
Table 1.  Significantly differentially expressed genes (SDEG), multiple hypothesis testing corrected 
p value < 0.05, across time and genotype points listed separately for up/downregulation (FC, fold change).
Comparison Group Gene list No. of SDEG No. of SDEG (|FC|> 2.0)
Between time points
WT
Up in WT E16.5 versus WT E14.5 2,421 1,675
Down in WT E16.5 versus WT E14.5 1694 134
HM
Up in HM E16.5 versus HM E14.5 3,153 1,936
Down in HM E16.5 versus HM E14.5 2,151 191
Between genotype
E14.5
Up in HM E14.5 versus WT E14.5 8 0
Down in HM E14.5 versus WT E14.5 5 0
E16.5
Up in HM E16.5 versus WT E16.5 30 10
Down in HM E16.5 versus WT E16.5 8 3
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ENSEMBLE gene ID Gene name Adjusted p value Fold change (HM E16.5/HM E14.5) Function
HM specific
24,330 Col11a2* 1.72E−27 6.16 Variants involved in  CP58,59
27,966 Col11a1* 2.63E−24 3.71 Variants involved in  CP58,59
32,060 Cryab* 5.97E−10 3.44 EMT  regulator
60,61
Apoptosis  inhibitor62,63
54,555 Adam12* 2.26E−19 2.9
TGFβ-induced EMT  regulator64
TGFβ signaling  modulator65
Epithelial cell proliferation and apoptosis  regulator66
22,483 Col2a1* 3.50E−06 2.68 Mutations involved in cleft  palate58,59
31,391 L1cam* 1.59E−04 2.38
Apoptosis  resistance67
EMT  regulator68
Cell  adhesion69
26,253 Chrng* 1.40E−02 2.21 Mutations associated with cleft  palate70
5,148 Klf5 1.17E−03 2.19 Epithelial proliferation  promotor
71
Apoptosis  inhibition72
22,037 Clu* 4.54E−05 2.18
TGFβ signaling  modulator73
Apoptosis  inhibitor74
TGFβ-induced EMT  regulator75
24,529 Lox* 3.14E−06 2.15 EMT  regulator
76,77
TGFβ signaling  target78
20,598 Nr-cam* 8.95E−03 2.15 Cell proliferation and motility  stimulator79
24,778 Fas* 4.34E−03 2.1 EMT  inducer
80
Apoptosis  mediator81,82
28,763 Hspg2* 2.78E−04 2.03 TGFβ signaling  target83
22,512 Cldn1* 1.32E−03 2.01 EMT  promotor
84,85
Apoptotic  regulator86,87
20,758 Itgb4 4.08E−03 2
EMT  promotor88
Epithelial Cells mobility  enhancer89,90
Apoptosis  inhibitor91
35,799 Twist1* 2.85E−13 − 2.17
CLP candidate  gene92,93
EMT  marker94–96
TGFβ signaling  regulator96,97
28,019 Pdgfc 1.74E−09 − 2.21 CP candidate  gene
1,98,99
TGFβ signaling  target100
21,994 Wnt5a* 4.44E−04 − 2.48 TGFβ signaling  crosstalk
101–103
EMT  mediator104,105
2,930 Ppp1r17 2.98E−02 − 2.52 Embryonic palate development  regulator25
48,450 Msx1 6.95E−10 − 2.66
CP candidate  gene106–108
EMT  mediator109
TGF-β superfamily pathways  regulator106
40,310 Alx4 2.16E−13 − 2.67 CP candidate  gene
110
EMT  mediator111,112
59,022 Kcp 7.83E−10 − 2.67 TGF-β superfamily pathways  regulator113
37,034 Pax1 3.22E−03 − 2.77 Embryogenesis  regulator
114
Apoptosis and differentiation  inducer115–117
18,486 Wnt9b 3.59E−05 − 4.88
CLP candidate  gene118,119
Facial outgrowth and fusion  promoter120
Cell proliferation, differentiation and cell polarity  regulator121,122
ENSEMBLE gene ID Gene name Adjusted p value Fold change (WT E16.5/WT E14.5) Function
WT specific
21,638 Ocln* 5.78E−10 2.84
Tight junction  component123
Adhesion, apoptosis, differentiation and homeostasis regulator in 
 keratinocytes124
27,858 Tspan2* 2.86E−07 2.49 Cell adhesion, proliferation, differentiation and migration  regulator
26
TGF-β signaling downstream  effector26
21,678 F2rl1* 1.73E−03 2.26 TGF-β signaling  target
125,126
Cell proliferation  enhancer127,128
42,228 Lyn* 1.37E−07 2.17
EMT  mediator129
Apoptosis  inhibitor130
TGF-β signaling  target131
303 Cdh1* 5.24E−03 2.09 CLP candidate  gene5,132,133
63,727 Tnfrsf11b 3.11E−03 2.04 TGF-β signaling pathways  mediator134,135
21,614 Vcan* 4.85E−30 − 2.66 Cell proliferation, adhesion and apoptosis  regulator
136,137
Apoptosis  inhibitor138,139
28,487 Bnc2 3.05E−05 − 2.76 Embryonic craniofacial mesenchymal cell multiplication  regulator140
30,498 Gas2 8.17E−05 − 3.06 Cell cycle and apoptosis  regulator
141
TGF-β signaling pathways  target142
Continued
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as Gsc is downregulated in WT palates. Similarly, uniquely in the HM, Tgf-β signaling downregulates a separate 
homeobox gene, Tlx2, a transcription factor (Fig. 3B). The Tlx2 gene encodes transcription factors essential in 
the development of neural-crest-derived cells suggesting a physiological role in the transcription-factor cascade 
underlying the differentiation of neuronal lineages during  embryogenesis42. We did not find any direct relation-
ship between TGF-β and Tlx2 but based on the fact that Tlx2 is crucial for neural-crest-derived cell development, 
it is therefore likely that palatal epithelia (which is an ectoderm derived cell) has limited or no role for Tlx2 and 
therefore it is downregulated.
Our upstream regulator analysis identified targets of Tgf-β in the WT specific gene list. Exploring the involve-
ment of these genes in the EMT and cell death mechanisms revealed limited involvement (Cdh1 and Lef1) of 
the EMT pathway (Supplementary Fig. 4a) whereas nine apoptotic genes (Ace, Cdh1, Dcn, Dlx2, Krt18, Pparg, 
Rasgrp, Sema7a, and Tnfrsf11b) were directly regulated by TGF-β (Supplementary Fig. 5a). We also identified 
mechanistic networks, which are interaction networks of upstream regulators that explain the changes observed 
in the WT (or HM) specific genes. When we explored the functional characteristics of these interconnected 
upstream regulators, none of the genes were involved in the EMT (Supplementary Fig. 4b); and 12 out of 14 
genes were involved in “cell death” (Supplementary Fig. 5b).
We identified genes regulated by Tgf-β3 in WT specific genes and showed that among these Tgf-β3 targets, 
Cdh1 is upregulated and Lef1 is downregulated (Supplementary Fig. 6). Loss of Cdh1 is a key marker of  EMT43; 
and the expression of Cdh1 can be repressed by the transcription factor Lef1 in palatal  EMT22,44. Additionally, 
anti-EMT cell–cell adhesion genes (Cdh1, Ocln, Tspan2) are upregulated, which may suggest a potential rela-
tionship between Tgf-β3 signaling and suppression of palatal EMT. These findings may indicate two possible 
outcomes: (a) since palatal seam disintegration is complete at E16.5, the EMT markers are no longer expressed, 
or (b) EMT may not be a mechanism of palatal seam disintegration. Our findings, based on mechanistic network 
and upstream regulator analysis (Supplementary Figs. 4a, 4b, 4a, 4b, and 4), suggest that the latter is more prob-
able as the number of apoptotic regulatory network genes are significantly more than the number of EMT genes.
Conclusion
Identifying transcripts that play key roles in regulating palatal development in critical stages has been a power-
ful approach to understanding how Tgf-β3 controls normal palatogenesis and how the lack of signaling (and its 
downstream signaling partners) is associated in induction of cleft palate. This study identifies potential CP-related 
genes based on differential expression between genotypes and gestational ages. The data presented in this work 
provide a strengthened understanding of the complex genetic mechanism of Tgf-β3-regulated palatogenesis. In 
addition, we discussed the variations in gene expression in the absence of Tgf-β3 in HM implicated in cleft pal-
ate. Our results represent a comprehensive analysis of the gene profile in murine cleft palate due to the absence 
of Tgf-β3. Further elucidation of the significantly up/downregulated genes will enhance our understanding of 
the mechanisms controlling palate development, thereby paving the way for prevention of cleft palate during 
development.
Methods
Animal selection and breeding. Tgf-β3 heterozygous (+/−) C57BL/6J breeder mice were obtained from 
Tom Doetschman (BIO5 Institute, University of Arizona, AZ). The reproduction and genotyping of Tgf-β3 −/− 
mice was conducted as previously  described9. Mice were accommodated and subject to procedures at the Uni-
versity of Nebraska Medical Center (UNMC) College of Dentistry Animal Facilities under the approval of the 
UNMC Institution Animal Care and Use Committee (IACUC # 06–064). Null mutant embryos were generated 
by intercrossing Tgf-β3 heterozygous male and female mice in a Mendelian fashion.
Genomic DNA purification and genotyping. Palatal tissues were dissected under the NIKON SMZ1000 
stereo microscope system (NIKON, Tokyo, Japan) from embryos collected on embryonic day (E) 14.5 and E16.5 
following the identification of vaginal plugs, which are considered to be E0.5. Palatal samples were stored in 
RNAlater Stabilization Reagent (QIAGEN, Hilgen, Germany) to preserve the gene expression profile and indi-
vidually labeled and matched with the corresponding tail tissue used for genotyping as detailed in our previous 
 study12.
Extraction of RNA, construction of small RNA libraries, and RNA-Seq. Two biological replicates 
from each genotype and gestational stage were designed to ensure reproducibility and rule out the possibility 
of differences caused by technical procedures. Palatal shelves were harvested in pairs from eight fetuses out of 
four litters. Each sample consisted of two pairs of palatal shelves dissected from fetuses of the same genotype 
from the same litter. The total RNA was purified using Arcturus PicoPure RNA Isolation Kit (THERMOFISHER 
ENSEMBLE gene ID Gene name Adjusted p value Fold change (WT E16.5/WT E14.5) Function
41,911 Dlx1* 7.45E−09 − 3.25 Craniofacial patterning  controller
143
TGF-β signaling pathways  inhibitor144,145
33,487 Fndc3c1 2.04E−21 − 4.58 Ectoderm differentiation  gene146
Table 2.  Selected genes that are uniquely significantly differentially expressed (adjusted p value < 0.05) in the 
HM or WT groups. CP, Cleft Palate; CL, Cleft Lip; CLP, Cleft Lip and Palate; identified in mouse or in human 
(*).
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Figure 3.  (A) IPA TGF-β signaling canonical pathway analysis overlaying the WT specific gene list: genes 
significantly differentially expressed (adjusted p < 0.05) with a |FC|> 2.0 uniquely in WT, E16.5 versus E14.5. 
Pink implies upregulation and green implies downregulation. Genes that are also involved in major non-Smad 
pathways (ERK/MAPK, p38MAPK and PI3-AKT) in palatogenesis are indicated with links to the corresponding 
pathways. (B) IPA TGF-β signaling canonical pathway analysis for the HM specific gene list: genes significantly 
differentially expressed (adjusted p < 0.05) with a |FC|> 2.0 uniquely in HM, E16.5 versus E14.5. Green implies 
downregulation. Genes that are also involved in major non-Smad pathways (ERK/MAPK, p38MAPK and PI3-
AKT) in palatogenesis are indicated with links to the corresponding pathways.
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Figure 4.  (A) Illustration of the level of mRNA expression showing fold change (log2) expression of the 
WT gene mRNA comparative to reference control genes (18rSRNA, GAPDH, and β-actin). The bar heights 
demonstrate mean expression of the genes in the WT samples. And the error bars suggest 95% confidence 
interval estimates of the mean expressions. One asterisk designates statistically significant difference between the 
means of a sample set in comparison to the mean of the control sample set (p value < 0.05); two asterisks indicate 
statistically significant difference (p value < 0.01). (B) Illustration of the level of mRNA expression showing 
fold change (log2) expression of HM gene mRNA comparative to reference control genes (18rSRNA, GAPDH, 
and β-actin). The bar heights demonstrate mean expression of the genes in HM samples. And the error 
bars suggest 95% confidence interval estimates of the mean expressions. One asterisk designates statistically 
significant difference between the means of a sample set in comparison to the mean of the control sample set 
(p value < 0.05); two asterisks indicate statistically significant difference (p value < 0.01).
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SCIENTIFIC, San Francisco, CA) to reliably extract high-quality RNA from a few cells by following the manu-
facturer’s protocols. Purity and concentration were measured by ultraviolet spectroscopy (NANODROP, Wilm-
ington, DE). The RNA integrity evaluation, construction of libraries, and validation was performed as described 
in our previous  study12.
RNA-seq analysis. RNA-seq data was obtained for four groups: two genotypes, Tgf-β3 −/− HM and Tgf-
β3 +/+ WT samples, profiled at two time points, embryonic days E14.5 and E16.5. Each group was represented 
by two biological replicates, resulting in eight samples. Each sample was run in two lanes on the ILLUMINA 
HISEQ2000 next generation sequencer using the 2 × 101 bp paired-end mode. Due to the high correlation coef-
ficient between them (r > 0.995) and in order to increase the coverage per biological sample and reduce the lane 
 effect45, lane data for each sample were pooled at the read level.
Raw reads were analyzed with FASTQC (V. 0.11.5) for quality  control46. Overrepresented (e.g., adapter and 
similar technical) sequences remaining in the raw reads were assessed and subsequently removed using TRIM-
MOMATIC (V. 0.36) in the palindrome mode based on default alignment detection and scoring  parameters47. 
Trimmomatic was also used for low quality base filtering. Maximum information quality filtering was employed 
with a minimum average read quality threshold of 25. Following technical sequence and low-quality base 
removal, reads that were shorter than 36 bp were filtered out.
Transcript quantification was done based on the GRCm38.p5 reference genome using Salmon (v. 0.8.2) 
with default  parameters48. Salmon uses sample-specific models, such as correction for GC-content bias, that 
improve the accuracy of transcription abundance estimates. We used transcripts per million (TPM) in Salmon’s 
output as the normalized relative abundance measure employed in our downstream analysis. Differential gene 
expression analysis was done using DESeq2 (Love, Huber et al. 2014), which has been shown to perform well in 
experimental designs with few  replicates49. The RNA-seq data used in this paper were deposited under NCBI’s 
Gene Expression Omnibus (GEO) database (Accession No.: GSE109838).
Clustering of samples and/or genes was done using the Unweighted Pair Group Method with Arithmetic Mean 
(UPGMA) method (also known as hierarchical clustering) with Pearson’s correlation as the distance  measure50. 
The expression data matrix was row-normalized prior to the application of average linkage clustering. The Data-
base for Annotation, Visualization and Integrated Discovery (DAVID) v6.751 was used for functional analysis 
of the gene lists, interrogating the Biological Process (BP), Molecular Function (MF), and Cellular Component 
(CC) Gene Ontology (GO)  categories52, and the Kyoto Encyclopedia of Genes and Genomes (KEGG)  pathways53. 
Biologically relevant categories that are overrepresented in the gene set and, therefore, may be of further interest 
were assessed using the Expression Analysis Systematic Explorer (EASE) score in the DAVID tool. The EASE 
score is the upper bound of the distribution of jackknife iterative resampling of Fisher’s exact probabilities with 
Bonferroni multiple testing correction. Categories containing low numbers of genes are underweighted so that 
the EASE score is more robust than the Fisher exact test. The EASE score is a significance level, with smaller 
EASE scores indicating increasing confidence in overrepresentation. We selected GO categories that have EASE 
scores of 0.05 or lower as significantly overrepresented.
We further analyzed the differentially expressed gene lists using the Ingenuity Pathway Analysis (IPA; QIA-
GEN Inc., https ://www.qiage nbioi nform atics .com/produ cts/ingen uity-pathw ay-analy sis) software. IPA is based 
on the manual curation of scientific literature to identify pathways, networks, and functional categories that are 
significantly represented in the input gene  list54. The computational analysis methods used in IPA are based on 
enrichment  approaches55,56 where pathways or functional groups in which the input gene lists are overrepresented 
are identified. By the same token, IPA identifies upstream regulators (e.g., transcription factors, microRNAs, 
kinases, compounds, or drugs) and generates interaction networks (based on known interactions identified in 
the literature) that best explain the transcriptional changes observed in the input gene list.
Table 3.  Epithelial-specific genes that are significantly differentially expressed (adjusted p value < 0.05, 
|FC|> 2.0) at E16.5 in HM versus WT. CLP, Cleft Lip and Palate; identified in mouse or in human (*).
ENSEMBLE gene ID Gene name Adjusted p value Fold change (HM E16.5/WT E16.5) Function
26,908 Eif2s3y* 4.39E−76 16.75 Mutations associated with  CLP147
20,592 Kdm5d* 2.35E−95 14.13 Mutations associated with palate  deformities148
22,290 Uty* 4.81E−45 8.69 Mutations associated with palate  deformities149
26,900 Ddx3y* 1.77E−25 5.78
Mutations associated with cleft 
 palate150
TGF-β signaling pathways  target151
20,248 Serpinb3a 0.000523 2.15 Epithelial hyperplasia and  hyperkeratosis152,153
245,026 Col6a6* 0.001059 2.13 Epithelial  hyperkeratosis154
16,682 Krt4 0.000106 2.09
Epithelial integrity  gene155
Epithelial cell differentiation 
 modulator156
333,564 Fndc3c1 0.000915 2.02 Ectoderm differentiation  gene146
57,294 Rps27* 0.000126 − 2.75 Mutations associated with cleft  palate157
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Confirmation of differentially expressed genes with qRT-PCR. To verify differentially expressed 
genes in Tgf-β3 WT and HM samples, qRT-PCR was undertake as previously  described19,57. Embryonic palates 
were extracted from at E14.5 and E16.5, and RNA extraction was conducted as previously  described19,57 using 
Arcturus PicoPure RNA Isolation Kit (THERMOFISHER SCIENTIFIC, San Francisco, CA) to reliably extract 
high-quality RNA from a few cells. RNA (500 ng) was converted to cDNA using Invitrogen Superscript IV VILO 
Master Mix (THERMOFISHER SCIENTIFIC, San Francisco, CA) that generated a significant cDNA yield at 
high temperatures in less time. An additional preamplification step was performed using TaqMan PreAmp Mas-
ter Mix (THERMOFISHER SCIENTIFIC, San Francisco, CA) with a custom preamplification pool of genes of 
interest to amplify small amounts of cDNA without introducing amplification bias. Samples were preamplified 
for 14 cycles with thermal cycling conditions of 95 °C for 15 s and 60 °C for 4 min followed by immediate place-
ment on ice. Finally, samples were diluted with TE buffer (ph 8.0) to 1:20 and were placed on 96-well custom 
array plates in technical triplicate and qRT-PCR executed with TaqMan Fast Advanced Master Mix (THER-
MOFISHER SCIENTIFIC, San Francisco, CA) reagents. Polymerase chain reaction conditions were run in 40 
cycles at 95 °C for 15 s, and 60 °C for 60 s. Following subtraction of technical repeat’s gene-specific ΔCtCt value 
from the housekeeping gene’s ΔCtCt value, the data were, then, analyzed using analysis of variance (ANOVA) on 
the repeat-normalized ΔΔCtCt values, including the control group; and translate effects were estimated from the 
ANOVA onto the multiplicative scale. The values of 29 genes tested were normalized by adjusting for the concen-
tration of established housekeeping gene, like 18S rRNA, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and β-actin and the ΔCt values of a naive/vehicle group.
Ethics approval and consent to participate. Tgf-β3 heterozygous (+/−) C57BL/6 J breeder mice were 
obtained from Tom Doetschman (BIO5 Institute, University of Arizona, AZ). The reproduction and genotyp-
ing of Tgf-β3 −/− mice was conducted as previously  described9. The live mice experiments were performed in 
accordance with the guidelines and regulations of the University of Nebraska Medical Center (UNMC) College 
of Dentistry Animal Facilities under the approval of the UNMC Institution Animal Care and Use Committee 
(IACUC # 18-088).
Data availability
The RNA-seq data used in this paper were deposited under NCBI’s Gene Expression Omnibus (GEO) database 
(Accession No.: GSE109838).
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